Lisa D. Belmont

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7

Ingrid E. Wertz, Saritha Kusam, Cynthia Lam et al. · Nature · 2011 · 806 citations

Protein Function, Medicine, Immune Checkpoint Inhibitor +9

Identification of a Protein That Interacts with Tubulin Dimers and Increases the Catastrophe Rate of Microtubules

Lisa D. Belmont, Timothy J. Mitchison · Cell · 1996 · 665 citations · Full text

Tubulin Dimers, Protein Function, Protein Folding +12

Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy

Darren C. Phillips, Michael J. Mitten, Erwin R. Boghaert et al. · Science Translational Medicine · 2015 · 530 citations · Full text

Cancer Therapy, Chemoprevention Strategy, Bcl-2/bcl-xl/bcl-w Inhibitor Abt-263 +20

Real-time visualization of cell cycle-dependent changes in microtubule dynamics in cytoplasmic extracts

Lisa D. Belmont, Anthony A. Hyman, Kenneth E. Sawin et al. · Cell · 1990 · 447 citations

Biology, Real-time Visualization, Cell Division +8

Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models

Elizabeth A. Punnoose, Franklin Peale, Erwin R. Boghaert et al. · Molecular Cancer Therapeutics · 2016 · 307 citations

Hematological Malignancy, Tumor Biology, Medicine +11